Search results
FTSE 100: GSK loses £4.5bn in value on Zantac lawsuit concerns
Yahoo Finance UK· 2 years agoGSK lost billions in value amid litigation concerns over the heartburn drug Zantac. Photo: Drew...
Pharma Stocks GSK, Sanofi And Haleon Lose Billions As Zantac Trial Looms
Investor's Business Daily· 2 years agoPharmaceutical stocks GSK, Sanofi and Haleon have wiped out a combined $31 billion in market cap...
FDA Head Questioned on Zantac’s Hidden Cancer Risk by Top Democrat DeLauro
Bloomberg via Yahoo News· 1 year ago(Bloomberg) -- The Food and Drug Administration’s chief is facing questions from a top lawmaker...
GSK's Relief For Few Months, First Trial Claiming Zantac Caused Cancer Pushed Into Late 2023
Benzinga via Yahoo Finance· 1 year agoThe first scheduled trial expected next week, related to GSK Plc's (NYSE: GSK) Zantac associated...
PFE, GSK & Other Pharma Stocks Hit by Zantac Litigation
Zacks via Yahoo Finance· 2 years agoBig pharma stocks, such as Glaxo (GSK), Sanofi (SNY), Pfizer (PFE) and Consumer stock Haleon (HLN),...
GSK attacks ‘meritless claims’ over heartburn drug Zantac
The Independent via Yahoo News· 2 years agoGSK and its consumer spin-off brand Haleon have hit back at market speculation over heartburn drug...
GSK, Sanofi shares soar as Zantac litigation fears abate
Reuters via Yahoo Finance· 1 year agoShares of GSK and Sanofi surged on Wednesday, adding more than $20 billion in combined value in...
First it was blood pressure medication. Now FDA eyes more drugs for cancer-causing chemical.
USA TODAY via Yahoo News· 1 year agoFor people managing high blood pressure, recalls of the carcinogen-tainted drug quinapril might...
GSK, Pfizer, Sanofi fend off thousands of U.S. lawsuits over alleged Zantac cancer link
Reuters via Yahoo News· 1 year agoDrugmakers GSK Plc, Pfizer Inc, Sanofi SA and Boehringer Ingelheim on Tuesday were spared thousands...
One Suit Down Out Of 3,000 Zantac Related Lawsuits, Says GSK
Benzinga via Yahoo Finance· 2 years agoGSK plc’s (NYSE: GSK) first scheduled Zantac related-cancer trial has been dismissed by the...